Geographic Shifts in Early-Stage Biopharmaceutical Innovation

This study examines changes from 2015 through 2025 in the country of origin of early-stage biopharmaceutical development programs worldwide.

Corresponding Author: So-Yeon Kang, PhD, MBA, Department of Health Management and Policy, Georgetown University School of Health, 3700 Reservoir Rd NW, Washington, DC 20007 (soyeon.kang@georgetown.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.